Capital Investment Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Capital Investment Advisory Services, LLC
- $916 Million
- Q2 2024
A detailed history of Capital Investment Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 10,655 shares of GILD stock, worth $882,447. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,655
Previous 13,096
18.64%
Holding current value
$882,447
Previous $959,000
23.77%
% of portfolio
0.08%
Previous 0.11%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.99 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.55 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.32 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.91 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $104B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...